Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients with Peritoneal Dissemination Yoshiyuki Fujiwara Gastrointestinal Oncology 23 August 2011 Pages: 187 - 188
Re: Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients with Peritoneal Dissemination Jung Ho ShimCho Hyun ParkKyo Young Song Gastrointestinal Oncology 23 August 2011 Pages: 189 - 189
HER2-Positive Gastric Cancer Haralabos Demetriades Gastrointestinal Oncology 16 August 2011 Pages: 190 - 191
Preventive and Therapeutic Implications of Positive CDH1 Testing in Diffuse Gastric Cancer Christof Hottenrott Gastrointestinal Oncology 15 July 2011 Pages: 192 - 193
Re: Aggressive Surgical Approach for Patients with T4 Gastric Carcinoma: Promise or Myth? Jung Ho ShimSeong Il OKyo Young Song Gastrointestinal Oncology 02 July 2011 Pages: 194 - 194
Letter to the Editor Reply to “Re: Aggressive Surgical Approach for Patients with T4 Gastric Carcinoma: Promise or Myth?” Ta-Sen Yeh Gastrointestinal Oncology 02 July 2011 Pages: 195 - 195
Oral Vitamin B12 Therapy Emmanuel AndrèsMustapha Mecili Gastrointestinal Oncology 28 June 2011 Pages: 196 - 198
Oral Vitamin B12 Therapy after Total Gastrectomy Hyoung-Il KimWoo Jin Hyung Gastrointestinal Oncology 30 June 2011 Pages: 199 - 199
Slow Progress in Predicting and Preventing Fatal Gastric Cancer Peritoneal Recurrence John SpiliotisEugenia Halkia Gastrointestinal Oncology 21 June 2011 Pages: 200 - 201
Peritoneal Carcinomatosis from Gastric Cancer: Current Considerations for Systematic Management and Future Tendencies for Identification of Valid Predictors Zhe SunHui-Mian Xu Gastrointestinal Oncology 23 June 2011 Pages: 202 - 205
Evidence Expands Total Gastrectomy Decision for Asymptomatic Patients with CDH1 Inherited Mutations T. Liakakos Gastrointestinal Oncology 17 June 2011 Pages: 206 - 207
Total Gastrectomy and Identified CDH1 Mutations: In Response Jeffrey A. NortonYijun Chen Gastrointestinal Oncology 13 July 2011 Pages: 208 - 208
The Impact of Calculation Procedure on the Hazard Ratio of N Classifications Cunjun YuZhu YingWenping Chen Gastrointestinal Oncology 03 June 2011 Pages: 209 - 210
Gastrectomy for Patients with Positive Peritoneal Cytology: Comments on the Article “Positive Peritoneal Cytology in Patients with Gastric Cancer: Natural History and Outcome of 291 Patients” Hiroshi OkabeYoshiharu Sakai Gastrointestinal Oncology 12 April 2011 Pages: 211 - 212
Positive Peritoneal Cytology in Gastric Cancer James J. MezhirManish A. ShahVivian E. Strong Gastrointestinal Oncology 13 April 2011 Pages: 213 - 214
Common Deficiencies in Clinical Researches of N Classifications for Gastric Cancer Cunjun YuWenting HePing Liu Gastrointestinal Oncology 23 March 2011 Pages: 215 - 215
Relationship Between the Prognostic Accuracy of Metastatic Lymph Node Ratio and the Number of Retrieved Nodes C. J. YuW. T. HeP. Liu Gastrointestinal Oncology 05 January 2011 Pages: 216 - 217
The American Society of Peritoneal Surface Malignancies (ASPSM) Jesus EsquivelAlexander StojadinovicEdward A. Levine Gastrointestinal Oncology 11 November 2010 Pages: 218 - 219
Surgical Management and Emerging Therapies to Prolong Survival in Metastatic Neuroendocrine Cancer Skye C. MayoMechteld C. de JongTimothy M. Pawlik Gastrointestinal Oncology 17 September 2010 Pages: 220 - 221
Surgical Management and Emerging Therapies to Prolong Survival in Metastatic Neuroendocrine Cancer Akshat SaxenaTerence C. ChuaDavid L. Morris Gastrointestinal Oncology 24 September 2010 Pages: 222 - 223
The Importance of Preoperative Staging with Chest CT Scan in Patients with Colorectal Cancer Raghava S. PavoorParul J. ShuklaJeffrey W. Milsom Colorectal Cancer 14 September 2010 Pages: 224 - 225
In Reply: The Importance of Preoperative Staging with Chest CT Scan in Patients with Colorectal Cancer Irene GrossmannJohannes AvenariusJoost Klaase Colorectal Cancer 28 August 2010 Pages: 226 - 227
Ex Vivo Sentinel Lymph Nodes in Pathological Staging of Node-Negative Colorectal Carcinoma Nadia PepariniPiero Chirletti Colorectal Cancer 11 November 2010 Pages: 228 - 228
Reply to “Ex Vivo Sentinel Lymph Nodes in Pathological Staging of Node-Negative Colorectal Carcinoma,” by Peparini and Chirletti Bruno MärklTherese Gannon Kerwel Colorectal Cancer 02 November 2010 Pages: 229 - 229
A Tale of Two Provinces: Regionalization of Pancreatic Surgery in Ontario and Quebec Marko SimunovicNancy Baxter Colorectal Cancer 20 January 2011 Pages: 230 - 230
Preanalytical Interferences Compromise the Clinical Validity of Matrix Metalloproteinase 1 as Marker of Colorectal Cancer Klaus Jung Colorectal Cancer 24 December 2010 Pages: 231 - 232
Reply: Preanalytical Interferences Compromise the Clinical Validity of Matrix Metalloproteinase 1 as Marker of Colorectal Cancer Masaaki IwatsukiKoshi MimoriMasaki Mori Colorectal Cancer 23 December 2010 Pages: 233 - 234
Prognostic Impact of Inferior Mesenteric Artery Lymph Node Metastasis in Colorectal Cancer Panagiotis TaflampasManousos ChristodoulakisEelco DeBree Colorectal Cancer 07 January 2011 Pages: 235 - 235
Reply about “Prognostic Impact of Inferior Mesenteric Artery Lymph Node Metastasis in Colorectal Cancer” Jeonghyun KangKang Young Lee Colorectal Cancer 12 January 2011 Pages: 236 - 236
Combined Resection of the Iliac Vessels for Lateral Pelvic Lymph Node Dissection can be Safely Performed Through Laparoscopic Approach Tsuyoshi KonishiHiroya KuroyanagiToshiaki Watanabe Colorectal Cancer 22 April 2011 Pages: 237 - 237
Technical Feasibility of Laparoscopic Lateral Pelvic Lymph Node Dissection for Patients with Low Rectal Cancer after Concurrent Chemoradiation Therapy: In Response Jin-Tung Liang Colorectal Cancer 22 April 2011 Pages: 238 - 238
Dual Role of Autophagy in Colon Cancer Cell Survival Shi Yu YangMarc C. Winslet Colorectal Cancer 21 May 2011 Pages: 239 - 239
High Ligation of Inferior Mesenteric Artery: A Standard Procedure for Colorectal Cancer? Theodore Liakakos Colorectal Cancer 02 July 2011 Pages: 240 - 241
Reply to “High Ligation of Inferior Mesenteric Artery: A Standard Procedure for Colorectal Cancer?” Jeonghyun KangKang Young Lee Colorectal Cancer 12 July 2011 Pages: 242 - 243
Distal Pancreatectomy Combined with Celiac Axis Resection in Treatment of Carcinoma of the Body/Tail of the Pancreas: Proceed with Caution Sun Hu YangKe Feng Dou Pancreatic Tumors 22 October 2010 Pages: 244 - 244
Distal Pancreatectomy Combined with Celiac Axis Resection: An Alternative Approach for Some Advanced Diatal Pancreatic Cancer Xubo WuRan TaoPeng Chongpeng Pancreatic Tumors 17 October 2010 Pages: 245 - 245
Erlotinib and Pancreatic Adenocarcinoma: Uncertainty and Hope Odysseas ZorasCharalambos Batsis Pancreatic Tumors 01 June 2011 Pages: 246 - 247
Does Pleomorphic Adenoma Really Require Total Parotidectomy? Poramate Pitak-ArnnopKittipong DhanuthaiNiels Christian Pausch Head and Neck Oncology 14 December 2010 Pages: 248 - 249
Central Compartment Reoperation for Recurrent/Persistent Differentiated Thyroid Cancer Ritesh AgrawalAnjali MishraSaroj Kanta Mishra Head and Neck Oncology 19 May 2011 Pages: 250 - 250
Endoscopic vs Robotic Thyroidectomy: Which is Better? Brian Hung-Hin LangMan Po ChowKai Pun Wong Head and Neck Oncology Open access 10 June 2011 Pages: 251 - 251
New Approaches in Thyroid Surgery: Is There an Increased Risk of Nerve Injury? Gianlorenzo DionigiManuel Duran-Poveda Head and Neck Oncology 30 June 2011 Pages: 252 - 253
Should Indications for Skin-Reducing Mastectomy be Expanded? Livio ColizziTommaso AgostiniDavide Lazzeri Breast Oncology 26 August 2010 Pages: 254 - 255
Authors Reply to “Should Indications for Skin-Reducing Mastectomy be Expanded?” Amit NairPilar Matey Reconstructive Oncology 28 August 2010 Pages: 256 - 256
Comments on: Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery (Clough KB, Kaufman GJ, et al. ASO DOI 10.1245/s10434-009-0792-y) F. SantanelliG. PaoliniB. Longo Breast Oncology 03 September 2010 Pages: 257 - 258
Reply to Comments on: Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery Krishna CloughGabriel KaufmanIsabelle Sarfati Breast Oncology 16 September 2010 Pages: 259 - 260
Anti-cytokeratin CAM5.2 (BD Biosciences) and CK8 Give No Remarkable Advantages to the Pancytokeratin Cocktail of Antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in Detecting Disseminated Tumor Cells in Biologic Subtypes of Stage I–III Breast Cancer Patients Wea-Lung LinFong-Lin ChenChih-Ping Han Breast Oncology 02 December 2010 Pages: 261 - 262
Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 Give No Remarkable Advantages to the Pancytokeratin Cocktail of Antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in Detecting Disseminated Tumor Cells in Biologic Subtypes of Stage I–III Breast Cancer Patients Savitri KrishnamurthyAnthony Lucci Breast Oncology 06 November 2010 Pages: 263 - 264
Comparing Prediction Models: The Distinction Between Clinical and Statistical Significance Anees B. ChagparKelly M. McMasters Breast Oncology 23 November 2010 Pages: 265 - 265
Expanding the Indications for Latissimus Dorsi Musculocutaneous Flap in Totally Autologous Breast Reconstruction: The Extended Variant Mario DiniFabio QuercioliTommaso Agostini Breast Oncology 21 December 2010 Pages: 266 - 270
Reply to “Letter to the Editor: Expanding the Indications for Latissimus Dorsi Musculocutaneous Flap in Totally Autologous Breast Reconstruction” Gedge D. Rosson Reconstructive Oncology 07 December 2010 Pages: 271 - 271